Watch Ticker

Y-mAbs Therapeutics, Inc. Common Stock

Go to Y-mAbs Therapeutics, Inc. Common Stock Website

$8.51

4.32 (103.10%)

Live

Previous Close

$4.19

Day Range

$8.495 - $8.54

Previous Day Range

$4.16 - $4.535

Market Cap

$205.2 million USD

Day Vol.

20.0 million

Previous Day Vol.

769202

Currency

USD

Primary Exchange

Nasdaq

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Halper Sadeh Llc - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA, YMAB, BASE, CORZ on Behalf of Shareholders

Law firm Halper Sadeh LLC is investigating potential securities law violations and fiduciary duty breaches for several companies undergoing mergers or acquisitions.

Related tickers: STAA, YMAB, BASE, CORZ, CORZW, CORZZ.

Read Full Article

Brodsky & Smith - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB), Couchbase, Inc. (Nasdaq – BASE), Core Scientific, Inc. (Nasdaq - CORZ)

Law firm Brodsky & Smith is investigating potential breaches of fiduciary duties by boards of several companies during merger and acquisition processes, focusing on whether shareholders are receiving fair value.

Related tickers: STAA, YMAB, CORZ, CORZW, CORZZ, BASE.

Read Full Article

Trending Tickers

Please sign in to view